{'fraction_non_alphanumeric': 0.022598870056497175, 'fraction_numerical': 0.0018832391713747645, 'mean_word_length': 6.823529411764706, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Extensively drug‐resistant carbapenemase‐producing Enterobacteriaceae: an emerging challenge for clinicians and healthcare systems

The global dissemination of carbapenem-resistant Enterobacteriaceae showing extensively drugresistant (XDR) phenotypes is one of the most worrying aspects of the ongoing ‘antibiotic resistance crisis’, in which antibiotics are progressively losing their efficacy due to the relentless increase in antibiotic resistance and the concomitant lag in the discovery and development of new antibiotics [1].